European Healthtech startup funding raised during H2 2010.
In H2 2010, 21 European Healthtech companies raised a combined €140M across 22 funding rounds, up 1.4% versus H2 2009. France led by capital raised, and Pitango Venture Capital was the most active investor. Data as of 7 Aug 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| SuperSonic Imagine | Series C | Nov 2010 | €35M |
| Kymab | Series A | Jul 2010 | €25M |
| NovImmune | Series D+ | Dec 2010 | €17M |
| EarlySense | Series C | Jul 2010 |
| €11M |
| uTest_Vamsi | Series C | Sep 2010 | €10M |
| Protagen | Series B | Sep 2010 | €10M |
| EarlySense | Series D+ | Oct 2010 | €5.1M |
| Global Imaging Online | Early VC | Jul 2010 | €4.8M |
| Alyotech | Early VC | Jul 2010 | €4.0M |
| Camero;Inc | Early VC | Aug 2010 | €3.1M |
| WiThings | Series A | Sep 2010 | €3.0M |
| CommProve | Early VC | Oct 2010 | €2.9M |
| Anaconda Pharma | Other | Jul 2010 | €2.9M |
| Phagenesis | Other | Sep 2010 | €2.8M |
| InSphero | Series A | Aug 2010 | €1.3M |
